Published :
Tables : 55
Figures : 49
Category : Healthcare
No. of Pages : 240
Report Code : HC-U9156
Dialysis Access Treatment Devices Market Overview: Hemodialysis access, also known as vascular access, is a method of obtaining blood for hemodialysis. Blood travels through soft tubes to the dialysis machine, where it is cleaned as it passes through a specific filter known as a dialyzer. A small operation is used to create an access. When the kidneys aren't working properly, dialysis helps to maintain electrolytes and fluid balance. Various dialysis equipment are often used to eliminate waste and fluid from the body. Furthermore, the COVID-19 infection has shown evidence of impacting the kidneys, causing damage to the organ and causing acute renal infection (AKI). The rise in incidence of end-stage renal disease (ESRD) patients around the world, the rise in the prevalence of diabetes in developing countries, and the global shortage of donor kidneys are all projected to enhance the growth of the dialysis access treatment devices market over the forecast period. Furthermore, the favourable repayment scenario offered for dialysis treatment in various countries, as well as research and development in both developed and developing economies, are propelling the dialysis access treatment devices market forward. Obstacles in treatment and an increase in the price of dialysis equipment, on the other hand, are two factors that will slow the growth of the dialysis access treatment devices market in the coming years. However, the rise in product recall issues may pose a significant obstacle to the dialysis access treatment devices market's growth in the near future. FutureWise Market Research has instantiated a report that provides an intricate analysis of Dialysis Access Treatment Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Dialysis Access Treatment Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Dialysis Access Treatment Devices Market: • Nipro • Rockwell Medical • Nikkiso Co., Ltd. • Asahi Kasei Medical Co., Ltd. • GIA Medical • Kawasumi Laboratories. INC. • NxStage Medical, Inc. • AngioDynamics • Baxter • Texas Instruments Incorporated • DaVita Inc. • Diaverum • Teleflex Incorporated • CVS Health, Home Dialysis Central • Quanta Dialysis Technologies • Dialifegroup.com • JMS Co.Ltd. • Henry Schein, Inc. • Covestro AG • Fresenius Kabi AG (Note: The list of the major players will be updated with the latest market scenario and trends) Dialysis Access Treatment Devices Market Segmentation: By Treatment • Home Hemodialysis • Hemodialysis • Peritoneal Dialysis By Types of Dialysis Membrane • Synthetic High-flux Membranes • Unmodified Cellulose Low-flux Membranes By Renal Products • Blood Tubing Set and Accessories • Dialysis Machine • Hemofilter • Endotoxin Retention Filter • Dialyzer • Arterial Venous By Disease Condition • Acute • Chronic By Application • Serum and Blood Treatment • Virus Purification • Salt Removal • Drug Binding Studies • Buffer Exchange • Other Applications By End-Users • Hospitals • Home Care Settings • Research Laboratories • Dialysis Centers • Clinics By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Dialysis Access Treatment Devices Market By Treatment, By Types of Dialysis Membrane, By Renal Products, By Disease Condition, By Application, By End-Users and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Hemodialysis access, also known as vascular access, is a method of obtaining blood for hemodialysis. Blood travels through soft tubes to the dialysis machine, where it is cleaned as it passes through a specific filter known as a dialyzer. A small operation is used to create an access. When the kidneys aren't working properly, dialysis helps to maintain electrolytes and fluid balance. Various dialysis equipment are often used to eliminate waste and fluid from the body. Furthermore, the COVID-19 infection has shown evidence of impacting the kidneys, causing damage to the organ and causing acute renal infection (AKI). The rise in incidence of end-stage renal disease (ESRD) patients around the world, the rise in the prevalence of diabetes in developing countries, and the global shortage of donor kidneys are all projected to enhance the growth of the dialysis access treatment devices market over the forecast period. Furthermore, the favourable repayment scenario offered for dialysis treatment in various countries, as well as research and development in both developed and developing economies, are propelling the dialysis access treatment devices market forward. Obstacles in treatment and an increase in the price of dialysis equipment, on the other hand, are two factors that will slow the growth of the dialysis access treatment devices market in the coming years. However, the rise in product recall issues may pose a significant obstacle to the dialysis access treatment devices market's growth in the near future.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Dialysis Access Treatment Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Dialysis Access Treatment Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Dialysis Access Treatment Devices Market: • Nipro • Rockwell Medical • Nikkiso Co., Ltd. • Asahi Kasei Medical Co., Ltd. • GIA Medical • Kawasumi Laboratories. INC. • NxStage Medical, Inc. • AngioDynamics • Baxter • Texas Instruments Incorporated • DaVita Inc. • Diaverum • Teleflex Incorporated • CVS Health, Home Dialysis Central • Quanta Dialysis Technologies • Dialifegroup.com • JMS Co.Ltd. • Henry Schein, Inc. • Covestro AG • Fresenius Kabi AG (Note: The list of the major players will be updated with the latest market scenario and trends)
Dialysis Access Treatment Devices Market Segmentation: By Treatment • Home Hemodialysis • Hemodialysis • Peritoneal Dialysis By Types of Dialysis Membrane • Synthetic High-flux Membranes • Unmodified Cellulose Low-flux Membranes By Renal Products • Blood Tubing Set and Accessories • Dialysis Machine • Hemofilter • Endotoxin Retention Filter • Dialyzer • Arterial Venous By Disease Condition • Acute • Chronic By Application • Serum and Blood Treatment • Virus Purification • Salt Removal • Drug Binding Studies • Buffer Exchange • Other Applications By End-Users • Hospitals • Home Care Settings • Research Laboratories • Dialysis Centers • Clinics By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Dialysis Access Treatment Devices Market By Treatment, By Types of Dialysis Membrane, By Renal Products, By Disease Condition, By Application, By End-Users and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Dialysis Access Treatment Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Dialysis Access Treatment Devices Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Dialysis Access Treatment Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Dialysis Access Treatment Devices Market, By Treatment Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Home Hemodialysis 7.1. Hemodialysis 7.1. Peritoneal Dialysis 8. Dialysis Access Treatment Devices Market, By Types of Dialysis Membrane Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Synthetic High-flux Membranes 8.1. Unmodified Cellulose Low-flux Membranes 9. Dialysis Access Treatment Devices Market, By Renal Products Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Blood Tubing Set and Accessories 9.2. Dialysis Machine 9.3. Hemofilter 9.4. Endotoxin Retention Filter 9.5. Dialyzer 9.6. Arterial Venous 10. Dialysis Access Treatment Devices Market, By Disease Condition Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Acute 10.2. Chronic 11. Dialysis Access Treatment Devices Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Serum and Blood Treatment 11.2. Virus Purification 11.3. Salt Removal 11.4. Drug Binding Studies 11.5. Buffer Exchange 11.6. Other Applications 12. Dialysis Access Treatment Devices Market, By End-Users Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. Hospitals 12.2. Home Care Settings 12.3. Research Laboratories 12.4. Dialysis Centers 12.5. Clinics 13. North America Dialysis Access Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. U.S.A 13.2.2. Canada 13.2.3. Mexico 13.3. Market Size (USD Million) Forecast for North America 2022-2028 14. Latin America Dialysis Access Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Brazil 14.2.2. Venezuela 14.2.3. Argentina 14.2.4. Rest of Latin America 14.3. Market Size (USD Million) Forecast for Latin America 2022-2028 15. Europe Dialysis Access Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Germany 15.2.2. U.K 15.2.3. France 15.2.4. Italy 15.2.5. Spain 15.2.6. Russia 15.2.7. Poland 15.2.8. Rest of Europe 15.3. Market Size (USD Million) Forecast for Europe 2022-2028 16. Asia Pacific Dialysis Access Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Japan 16.2.2. China 16.2.3. India 16.2.4. Australia and New Zealand 16.2.5. ASEAN 16.2.6. Rest of Asia Pacific 16.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 17. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. GCC 17.2.2. Israel 17.2.3. South Africa 17.2.4. Rest of MEA 17.3. Market Size (USD Million) Forecast for MEA 2022-2028 18. Market Share Analysis and Competitive Landscape 18.1. Global Landscape - Key Players, Revenue and Presence 18.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 18.3. Global Emerging Companies 18.4. North America - Market Share Analysis and Key Regional Players 18.5. Europe - Market Share Analysis and Key Regional Players 18.6. Asia Pacific - Market Share Analysis and Key Regional Players 18.7. Global Key Player - Growth Matrix 19. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 19.1. Nipro 19.1.1. Company Overview 19.1.2. Product Portfolio 19.1.3. SWOT Analysis 19.1.4. Financial Overview 19.1.5. Strategic Overview 19.2. Rockwell Medical 19.2.1. Company Overview 19.2.2. Product Portfolio 19.2.3. SWOT Analysis 19.2.4. Financial Overview 19.2.5. Strategic Overview 19.3. Nikkiso Co., Ltd. 19.3.1. Company Overview 19.3.2. Product Portfolio 19.3.3. SWOT Analysis 19.3.4. Financial Overview 19.3.5. Strategic Overview 19.4. Asahi Kasei Medical Co., Ltd. 19.4.1. Company Overview 19.4.2. Product Portfolio 19.4.3. SWOT Analysis 19.4.4. Financial Overview 19.4.5. Strategic Overview 19.5. GIA Medical 19.5.1. Company Overview 19.5.2. Product Portfolio 19.5.3. SWOT Analysis 19.5.4. Financial Overview 19.5.5. Strategic Overview 19.6. Kawasumi Laboratories. INC. 19.6.1. Company Overview 19.6.2. Product Portfolio 19.6.3. SWOT Analysis 19.6.4. Financial Overview 19.6.5. Strategic Overview 19.7. NxStage Medical, Inc. 19.7.1. Company Overview 19.7.2. Product Portfolio 19.7.3. SWOT Analysis 19.7.4. Financial Overview 19.7.5. Strategic Overview 19.8. AngioDynamics 19.8.1. Company Overview 19.8.2. Product Portfolio 19.8.3. SWOT Analysis 19.8.4. Financial Overview 19.8.5. Strategic Overview 19.9. Baxter 19.9.1. Company Overview 19.9.2. Product Portfolio 19.9.3. SWOT Analysis 19.9.4. Financial Overview 19.9.5. Strategic Overview 19.10.Texas Instruments Incorporated 19.10.1. Company Overview 19.10.2. Product Portfolio 19.10.3. SWOT Analysis 19.10.4. Financial Overview 19.10.5. Strategic Overview 19.11.DaVita Inc. 19.11.1. Company Overview 19.11.2. Product Portfolio 19.11.3. SWOT Analysis 19.11.4. Financial Overview 19.11.5. Strategic Overview 19.12.Diaverum 19.12.1. Company Overview 19.12.2. Product Portfolio 19.12.3. SWOT Analysis 19.12.4. Financial Overview 19.12.5. Strategic Overview 19.13.Teleflex Incorporated 19.13.1. Company Overview 19.13.2. Product Portfolio 19.13.3. SWOT Analysis 19.13.4. Financial Overview 19.13.5. Strategic Overview 19.14.CVS Health, Home Dialysis Central 19.14.1. Company Overview 19.14.2. Product Portfolio 19.14.3. SWOT Analysis 19.14.4. Financial Overview 19.14.5. Strategic Overview 19.15.Quanta Dialysis Technologies 19.15.1. Company Overview 19.15.2. Product Portfolio 19.15.3. SWOT Analysis 19.15.4. Financial Overview 19.15.5. Strategic Overview 19.16.Dialifegroup.com 19.16.1. Company Overview 19.16.2. Product Portfolio 19.16.3. SWOT Analysis 19.16.4. Financial Overview 19.16.5. Strategic Overview 19.17.JMS Co.Ltd. 19.17.1. Company Overview 19.17.2. Product Portfolio 19.17.3. SWOT Analysis 19.17.4. Financial Overview 19.17.5. Strategic Overview 19.18.Henry Schein, Inc. 19.18.1. Company Overview 19.18.2. Product Portfolio 19.18.3. SWOT Analysis 19.18.4. Financial Overview 19.18.5. Strategic Overview 19.19.Cove9tro AG 19.19.1. Company Overview 19.19.2. Product Portfolio 19.19.3. SWOT Analysis 19.19.4. Financial Overview 19.19.5. Strategic Overview 19.20.Fresenius Kabi AG 19.20.1. Company Overview 19.20.2. Product Portfolio 19.20.3. SWOT Analysis 19.20.4. Financial Overview 19.20.5. Strategic Overview 20. Pre and Post COVID-19 Impact 20.1. Positive influence on the healthcare industry 20.2. The financial disruption of the manufacturing sector 20.3. Impact of COVID-19 on emerging companies 20.4. Significant mandates in the healthcare regulations initiated by administrations 20.5. The overall economic slowdown of the developing and developed nations 21. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics